Medtronic Obesity Management
Clinical Research Study for Obesity
Thank you for your interest in Medtronic Obesity Management and Gastric Electrical Stimulation.
Obesity is a growing worldwide epidemic. In the United States, nearly one-third of adults are obese. Given the prevalence of the condition, and the numerous medical disorders associated with excess weight gain, there remains a significant unmet medical need for effective treatment.
Medtronic has a rich heritage in using electrical stimulation to treat an array of chronic diseases. The Obesity Management division was created in 2005 to apply this technological approach to treat obesity.
What is Gastric Electrical Stimulation?
NOTE: Gastric Electrical Stimulation therapy has not been approved by the Food and Drug Administration (FDA) and is for investigational use only in the United States.
U.S. Clinical Trials
Medtronic is currently not enrolling in any clinical studies in the U.S. This site will be updated once we begin enrolling into the next clinical study
Clinical Research Study for Obesity
Thank you for your interest in Medtronic Obesity Management and Gastric Electrical Stimulation.
Obesity is a growing worldwide epidemic. In the United States, nearly one-third of adults are obese. Given the prevalence of the condition, and the numerous medical disorders associated with excess weight gain, there remains a significant unmet medical need for effective treatment.
Medtronic has a rich heritage in using electrical stimulation to treat an array of chronic diseases. The Obesity Management division was created in 2005 to apply this technological approach to treat obesity.
What is Gastric Electrical Stimulation?
- Gastric Electrical Stimulation (GES) employs an implantable, pacemaker-like device to deliver low-level electrical stimulation to the stomach.
- The procedure involves the surgeon suturing electrical leads to the outer lining of the stomach wall. The leads are then connected to the device, which is implanted just under the skin in the abdomen. Using an external programmer that communicates with the device, the surgeon will establish the level of electrical stimulation appropriate for the patient.
- While the exact way in which GES causes weight loss is not fully understood, it is believed that through low-level electrical pulses the therapy slows the intrinsic electrical waves in the stomach. Animal studies have shown that this electrical stimulation causes the stomach to relax, resulting in distension of the stomach. This distension triggers nerves in the stomach involved in digestion to send signals via the central nervous system to the brain that the stomach is “full”. Additional research is being conducted to better understand how stimulation affects the digestive system.
NOTE: Gastric Electrical Stimulation therapy has not been approved by the Food and Drug Administration (FDA) and is for investigational use only in the United States.
U.S. Clinical Trials
Medtronic is currently not enrolling in any clinical studies in the U.S. This site will be updated once we begin enrolling into the next clinical study